http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1057830-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f4c2477bdea308bc9dec3feded37457 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7da6793996e8856030e5312ac91ee54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_404f6ddacc6313b769636cfc1030a077 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04 |
| filingDate | 1999-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4692ff23119ff13631e114f434d5d592 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1486d15eedc64a8a98f969b2459e7b0a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b34d26c8fa95b6cfea45699b7c2ad46b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_306887ff57abafc630087dd2e5fbe7ff http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c119e436f775a8277feb47153a62945 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b844e31053433494e9c728f94dfb6d53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f388bd7392be87a7ac0c8f0415ca28b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a03cc3de33c8efdea5bf9fe66faa053b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f963499d3ac56af8dd92d1a3c90b1910 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0740596a689cb415a0a64c28a3e8f19f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7492be0fbd2e73fe70fbe9babd2d89f4 |
| publicationDate | 2000-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1057830-A1 |
| titleOfInvention | Heterocycle-fused benzothiazine derivatives |
| abstract | The invention provides a novel heterocyclic ringncondensed benzothiazine compound which is effective fornprevention or remedy of disease, in which histamine,nleukotriene and the like participate. The heterocyclic ringncondensed benzothiazine compound of the present invention orna pharmacologically acceptable salt thereof is effective fornprevention or remedy of disease, in which a chemical mediator,nsuch as histamine, leukotriene and the like, participate, fornexample, asthma, allergic coryza, atopic dermatitis, hives, haynfever, gastrointestinal allergy, food allergy and the like.nFurther, the heterocyclic ring condensed benzothiazinencompound of the present invention, its pharmacologicallynacceptable salt or hydrates thereof is represented by thenfollowing formula:n nIn the formula, the ring Het represents an unsaturatednheterocyclic ring; R 1 and R 2 are the same as or different fromneach other, and each represents halogen atom, a lower alkylngroup that may be substituted with a halogen atom, a lower alkoxyngroup that may be substituted with a halogen atom, a lower alkyl nlower alkoxy group, cyano group; D represents a lower alkylenengroup and the like that may have a substituent; Q represents,nfor example, the formula -NR 20 R 21 (in the formula, R 20 and R 21 arenthe same as or different from each other, and each representsnhydrogen atom, a lower alkyl group that may be substituted withna halogen atom, an aryl group that may have a substituent, annarylalkyl group that may have a substituent, a heteroaryl groupnthat may have a substituent or a heteroarylalkyl group that maynhave a substituent, or R 20 and R 21 may form a 3- to 8-memberednring along with the nitrogen atom to which they are bound); andnx represents an integer of from 1 to 2. |
| priorityDate | 1998-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 650.